|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 471/04 | |
| A61K 31/506 | |||
| A61P 37/00 |
| (11) | Number of the document | 3350179 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16769914.9 |
| Date of filing the European patent application | 2016-09-14 | |
| (97) | Date of publication of the European application | 2018-07-25 |
| (45) | Date of publication and mention of the grant of the patent | 2021-01-13 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2016/071637 |
| Date | 2016-09-14 |
| (87) | Number | WO 2017/046125 |
| Date | 2017-03-23 |
| (30) | Number | Date | Country code |
| PCT/EP2015/0710 | 2015-09-15 | WO |
| (72) |
AISSAOUI, Hamed, CH
BOSS, Christoph, CH
BOUIS, Patrick, CH
HAZEMANN, Julien, CH
SIEGRIST, Romain, CH
VON RAUMER, Markus, CH
|
| (73) |
Idorsia Pharmaceuticals Ltd,
Hegenheimermattweg 91, 4123 Allschwil,
CH
|
| (54) | CRYSTALLINE FORMS |
| CRYSTALLINE FORMS |